1. Home
  2. RNXT vs FEAM Comparison

RNXT vs FEAM Comparison

Compare RNXT & FEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • FEAM
  • Stock Information
  • Founded
  • RNXT 2012
  • FEAM 2016
  • Country
  • RNXT United States
  • FEAM United States
  • Employees
  • RNXT N/A
  • FEAM N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • FEAM Major Chemicals
  • Sector
  • RNXT Health Care
  • FEAM Industrials
  • Exchange
  • RNXT Nasdaq
  • FEAM Nasdaq
  • Market Cap
  • RNXT 31.6M
  • FEAM 29.9M
  • IPO Year
  • RNXT 2021
  • FEAM N/A
  • Fundamental
  • Price
  • RNXT $1.15
  • FEAM $0.35
  • Analyst Decision
  • RNXT Strong Buy
  • FEAM Strong Buy
  • Analyst Count
  • RNXT 2
  • FEAM 2
  • Target Price
  • RNXT $6.50
  • FEAM $5.63
  • AVG Volume (30 Days)
  • RNXT 112.1K
  • FEAM 204.8K
  • Earning Date
  • RNXT 03-31-2025
  • FEAM 02-18-2025
  • Dividend Yield
  • RNXT N/A
  • FEAM N/A
  • EPS Growth
  • RNXT N/A
  • FEAM N/A
  • EPS
  • RNXT N/A
  • FEAM N/A
  • Revenue
  • RNXT N/A
  • FEAM N/A
  • Revenue This Year
  • RNXT N/A
  • FEAM N/A
  • Revenue Next Year
  • RNXT N/A
  • FEAM $146.88
  • P/E Ratio
  • RNXT N/A
  • FEAM N/A
  • Revenue Growth
  • RNXT N/A
  • FEAM N/A
  • 52 Week Low
  • RNXT $0.77
  • FEAM $0.34
  • 52 Week High
  • RNXT $1.86
  • FEAM $2.48
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 58.08
  • FEAM 40.26
  • Support Level
  • RNXT $1.32
  • FEAM $0.35
  • Resistance Level
  • RNXT $1.40
  • FEAM $0.48
  • Average True Range (ATR)
  • RNXT 0.11
  • FEAM 0.06
  • MACD
  • RNXT 0.00
  • FEAM -0.01
  • Stochastic Oscillator
  • RNXT 39.47
  • FEAM 19.05

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

Share on Social Networks: